GlobalData on MSN15h
GSK gains approval in Japan for extended indication of RSV vaccine
GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...
GSK eyes up combo approval for previously withdrawn myeloma drug
The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.
GSK :FDA Accepts Blenrep Combination For Review In Treatment Of Relapsed/Refractory Multiple Myeloma
GSK plc (GSK, GSK.L) announced that the US Food and Drug Administration has accepted for review a Biologics License Application (BLA) ...
GSK’s Blenrep Nears FDA Review for Myeloma
GlaxoSmithKline (GB:GSK) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now ...
The Pharma Letter14h
FDA signals progress on the western front for belantamab mafodotin
The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for belantamab ...
GSK's Blenrep treatment accepted for review by FDA
Pharma titan GSK has announced that US regulators have accepted for review Blenrep combinations for the treatment of relapsed ...
Musk's Neuralink to launch feasibility trial with brain implant, robotic arm
Elon Musk's Neuralink received approval to launch a new feasibility trial using its brain implant and an investigational ...
GSK's Blenrep combinations accepted for review by US FDA
GSK PLC said on Monday that the US Food & Drug Administration accepted a biologics license application for its Blenrep combinations for the treatment of relapsed and refractory multiple myeloma, both ...
Pharmabiz3h
US FDA accepts for review GSK’s Blenrep combinations for the treatment of relapsed/refractory multiple myeloma
US FDA accepts for review GSK’s Blenrep combinations for the treatment of relapsed/refractory multiple myeloma: London, UK Tuesday, November 26, 2024, 09:00 Hrs [IST] GSK plc an ...
This tech stock is down by 75pc and isn’t recovering – it’s time to sell
The debate continues to rage over the perceived rights and wrongs of October’s Budget. All this column will add is that, as ...
Ex-RTE star helps to raise awareness on ‘serious’ RSV – everything to know from signs, symptoms & risk factors
BETWEEN colds, flus and Covid, we thought we knew all the big winter worries – but what about RSV? Respiratory syncytial ...
3 Reasons Why Biodiversity Has Become Front And Center For Business
Investors and companies are recognizing the economic cost of nature and biodiversity loss and acting to protect the global economy that depends on thriving ecosystems.